Log In

Status Information

Status
DISCOURAGED
Comment
The Method values "Screen" and "Confirm" reflect a regulatory testing requirement rather than an actual laboratory method. This term has been discouraged in favor of terms specifying the true method (Immunoassay or Mass Spectrometry) or a methodless term where appropriate. Please select the replacement term that matches your actual testing method.

Part Descriptions

LP269521-3   Methamphetamine+Methylenedioxymethamphetamine
Methylenedioxymethamphetamine (MDMA) (3,4-methylenedioxymethamphetamine) is an empathogenic drug of the phenethylamine and amphetamine classes of drugs. Amphetamines and phenethylamines are a class of chemicals/drugs that are synthetic, psychoactive drugs. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation. In 1985, the US Drug Enforcement Administration moved the drug to Schedule 1 status with no accepted medical use. Source: Regenstrief LOINC, MDMA

LP269521-3   Methamphetamine+Methylenedioxymethamphetamine
Methamphetamine (MA) is a drug of abuse also referred to as meth, crystal and speed. It is a central nervous system stimulant that can be injected, smoked, snorted or ingested. Short-term MA abuse causes an increase of energy, sense of well-being and decreased appetite that lasts 6-8 hours. PMID: 19042205 MA use can lead to stroke, cardiac arrhythmia, stomach cramps, shaking, anxiety, insomnia, paranoia, hallucinations, and structural changes to the brain. Pregnant women who use MA can cause growth retardation, premature birth, and developmental disorders in neonates and long lasting intellectual deficits to the children as they grow. PMID: 10908000 Users addicted to MA experience withdrawal symptoms that include dysphoria, fatigue, insomnia and an increased appetite. In chronic MA users positron emission tomography has proven a decrease in dopamine D2 receptors which is associated with mental deterioration that can be reversed to some extent after abstaining from MA. PMID: 19042205 Source: Regenstrief LOINC

LOINC Names Get Info

Fully-Specified Name
Methamphetamine+Methylenedioxymethamphetamine:PrThr:Pt:Tiss:Ord:Screen
Long Common Name
Methamphetamine+Methylenedioxymethamphetamine [Presence] in Tissue by Screen method
Short Name
Methamphet+MDMA Tiss Ql Scn
Display Name
Methamphetamine+MDMA Screen Ql (Tiss)
Consumer Name Alpha Get Info
Methamphetamine+MDMA, Tissue

Part Model Get Info

  • Component
    Methamphetamine+Methylenedioxymethamphetamine
    LP269521-3
    • Analyte
      Methamphetamine+Methylenedioxymethamphetamine
      LP269521-3
      • Component Numerator
        Methamphetamine+Methylenedioxymethamphetamine
        LP269521-3
        • Component Numerator Core
          Methamphetamine+Methylenedioxymethamphetamine
          LP269521-3
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    PrThr
    LP217195-9
  • Time
    Pt
    LP6960-1
  • System
    Tiss
    LP7641-6
    • System Core
      Tiss
      LP7641-6
    • Super System
      NULL
       
  • Scale
    Ord
    LP7751-3
  • Method
    Screen
    LP6503-9

Example Answer List: LL2355-7

Source: Laboratory Corporation of America
AnswerCodeScoreAnswer ID
PositiveCopyright http://snomed.info/sct ID:10828004 Positive (qualifier value)LA6576-8
None detectedLA19544-8

Basic Attributes

Class
DRUG/TOX
Type
Laboratory
First Released
Version 2.65
Last Updated
Version 2.83 (MIN)
Order vs. Observation
Both

Member of these Panels

LOINCLong Common Name
91055-4Drugs of abuse panel - Tissue

Member of these Groups Get Info

LOINC GroupGroup Name
LG50150-8Methamphetamine+Methylenedioxymethamphetamine|ANYProp|ANYTm|ANYSys|ANYMeth

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Metamfetamin+methylendioxymetamfetamin:Přítomnost nebo práh:Časový bod:Tkáně a stěry:Ordinální:Screening toxikologický
el-GRGreek (Greece)Μεθαμφεταμίνη+Μεθυλενοδιοξυμεθαμφεταμίνη:PrThr:Pt:Ιστός:Ord:Έλεγχος
Synonyms: DRUG/TOX Ord PrThr Pt Έλεγχος Ιστός Μεθαμφεταμίνη Μεθαμφεταμίνη+Μεθυλενοδιοξυμεθαμφεταμίνη Μεθυλενοδιοξυμεθαμφεταμίνη
es-ESSpanish (Spain)Metanfetamina + Metilendioximetanfetamina:PrThr:Punto temporal:Tejido:Ord:Cribado toxicológico
es-MXSpanish (Mexico)Metanfetamina + Metilendioximetanfetamina:Presencia o umbral:Punto temporal:Tejido y frotis:Ordinal:Pantalla de toxicología
fr-FRFrench (France)Methamphétamine+méthylènedioxymethamphétamine:Présence/Seuil:Ponctuel:Tissu:Qualitatif:Dépistage
it-ITItalian (Italy)Metanfetamina+Metilenediossimetanfetamina:PrThr:Pt:Tessuto:Ord:Screening
Synonyms: Livelli farmacologici e tossicologia Presenza o Soglia Punto nel tempo (episodio) Screening tossicologico Tessuto & Strisci
zh-CNChinese (China)甲基苯丙胺+亚甲基二氧甲基苯丙胺:存在情况或阈值:时间点:组织与涂片:序数型:毒理学筛查试验
Synonyms: C10H15N;去氧麻黄碱;甲基苯异丙胺;脱氧麻黄碱 亚甲基二甲氧基苯丙胺;亚甲基二甲氧基苯异丙胺;甲烯二氧甲苯丙胺;摇头丸 依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值） 时刻;随机;随意;瞬间 未作说明的组织;组织;组织 & 涂片 毒品 毒品类 甲基苯丙胺（去氧麻黄碱、甲基苯异丙胺、脱氧麻黄碱）+亚甲基二氧甲基苯丙胺（亚甲基二甲氧基苯丙胺、亚甲基二甲氧基苯异丙胺、甲烯二氧甲苯丙胺、摇头丸） 筛查 筛查方法;筛查法;筛查试验 筛查试验 筛选试验 药品类 药物 药物/毒理学;药物/毒理学试验;药物毒理学试验;药物毒理学试验类 药物类 过筛 过筛试验

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=91051-3